BIG PHARMA'S NOT THE CASH COW IT WAS—TIME FOR INVESTORS TO EXIT
Investor returns are on the line
BIG PHARMA OWNS NOTHING BUT PATENTS
In this article Taking Over Big Pharma Plants, we get a flavour for the scale of outsourcing Big Pharma had been cracking on with:
“AstraZeneca intends to outsource all its active pharmaceutical ingredient (API) production over the next five to seven years. Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., and Pfizer …
Keep reading with a 7-day free trial
Subscribe to INSIDE PHARMA to keep reading this post and get 7 days of free access to the full post archives.